Low-dose recombinant factor VIIa for trauma patients with coagulopathy

Injury

Volumn 39, Issue 9, 2008, Pages 1054-1061

  Stein, Deborah M ^a   Dutton, Richard P ^a   Hess, John R ^a   Scalea, Thomas M ^a  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

Author keywords

Coagulopathy; Thromboembolic complications; Trauma; Traumatic brain injury

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; HEART ATRIUM THROMBOSIS; HEART INFARCTION; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; STUDENT T TEST; THROMBOEMBOLISM; THROMBOSIS; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; BLOOD COAGULATION DISORDERS; COHORT STUDIES; FACTOR VIIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; WOUNDS AND INJURIES;

EID: 48649084482     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2008.03.032     Document Type: Article

References (51)

1. Barnes C., Blanchette V., Canning P., et al. Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med 15 April (2) (2005) 145-150
2. Bernstein D.E., Jeffers L., Erhardtsen E., et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113 December (6) (1997) 1930-1937
3. Berntorp E., Stigendal L., Lethagen S., et al. NovoSeven in warfarin-treated patients. Blood Coag Fibrin 11 Suppl. 1 (2000) S113-S115
4. Billio A., Morello E., Amaddii G., et al. Treatment of refractory thrombocytopenic bleeding with rFVIIa: a case report. Blood 100 (2002) 83b
5. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 July (1) (2005) 8-15 [discussion 15-8]
6. Brody D.L., Aiyagari V., Shackleford A.M., et al. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2 3 (2005) 263-267
7. Carrick M.M., Tyroch A.H., Youens C.A., and Handley T. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma 58 April (4) (2005) 725-729 [discussion 729-30]
8. Cortiana M., Zagara G., Fava S., and Seveso M. Coagulation abnormalities in patients with head injury. J Neurosurg 30 July-September (3) (1986) 133-138
9. Culic S. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 120 March (5) (2003) 909-910
10. da Silva Viana J. Recombinant factor VIIa in major abdominal surgery and liver transplantation. Transplant Proc 38 April (3) (2006) 818-819
11. Deveras R.A.E., and Kessler C.M. Reversal of warfarin-induced excessive anticoagulation with recombinant factor VII concentrate. Ann Intern Med 137 (2002) 884-888
12. Dutton R.P., Hess J.R., and Scalea T.M. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 15 (2003) 184-188
13. Dutton R.P., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 57 (2004) 709-719
14. Eikelboom J.W., Bird R., Blythe D., et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coag Fibrin 14 (2003) 713-717
15. Freeman W.D., Brott T.G., Barrett K.M., et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79 December (12) (2004) 1495-1500
16. Friederich P.W., Henny C.P., Messelink E.J., et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet 361 (2003) 201-205
17. Geeraedts Jr. L.M., Kamphuisen P.W., Kaasjager H.A., et al. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma. Injury 36 April (4) (2005) 495-500 [Epub 2004 December 8].
18. Gerotziafas G.T., Zervas C., Gavrielidis G., et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 69 (2002) 219-222
19. Haan J., and Scalea T. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. Am Surg 71 May (5) (2005) 414-415
20. Harrison T.D., Laskosky J., Jazaeri O., et al. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 59 July (1) (2005) 150-154
21. Hedner U. Factor VIIa in the treatment of hemophilia. Blood Coag Fibrin 1 (1990) 307-317
22. Hulka F., Mullins R., and Frank E. Blunt brain injury activates the coagulation process. Arch Surg 131 September (9) (1996) 923-927 [discussion 927-8]
23. Jabbour N., Gagandeep S., Peilin A.C., et al. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation. Am Surg 71 February (2) (2005) 175-179
24. Jeffers L., Chalasani N., Balart L., et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 123 July (1) (2002) 118-126
25. Kenet G., Walden R., Eldad A., and Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354 (1999) 1879
26. Khan A.Z., Parry J.M., Crowley W.F., et al. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage. Am J Surg 189 March (3) (2005) 331-334
27. Klamroth R., Gottstein S., and Landgraf H. Successful use of recombinant factor VIIa to prevent bleeding during major surgery in a patient with severe immune thrombocytopenia. Blood 100 (2002) 77b
28. Levi M., Peters M., and Buller H. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systemic review. Crit Care Med 33 April (4) (2005) 883-890
29. Levy J.H., Fingerhut A., Brott T., et al. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46 June (6) (2006) 919-933
30. Lin J., Hanigan W.C., Tarantino M., et al. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 98 April (4) (2003) 737-740
31. Lodge J.P., Jonas S., Oussoultzoglou E., et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 February (2) (2005) 269-275
32. Lodge P., Jonas S., Jaeck D., et al. Recombinant factor VIIa in partial hepatectomy: a randomized placebo-controlled, double-blind clinical trial. J Hepatol 36 (2003) 177
33. Martinowitz U., Kenet G., Lubetski A., et al. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 49 (2002) S15-S20
34. Martinowitz U., Kenet G., Segal E., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51 (2001) 431-439
35. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 February (8) (2005) 777-785
36. Mindikoglu A.L., Anantharaju A., George M., et al. Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa. Dig Dis Sci 48 (2003) 1130-1135
37. Mindikoglu A.L., Anantharaju A., Villanueva J., et al. Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest 123 (2003) 956-958
38. Minniti C., and Weinthal J. Use of recombinant activated factor VII (rFVIIa) in two children with idiopathic thrombocytopenia pupura (ITP). Blood 98 (2001) 62b
39. Morenski J.D., Tobias J.D., and Jimenez D.F. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. J Neurosurg 98 March (3) (2003) 611-616
40. O'Connell N.M., Perry D.J., Hodgson A.J., et al. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 43 (2003) 1711-1716
41. Pardo M., Bartolome J., Carreno V., et al. Benefit of rFVIIa administration for cirrhotic patients undergoing surgery. World J Surg 27 (2003) 758-759
42. Park P., Fewel M.E., Garton H.J., et al. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophiliac neurosurgical patients. Neurosurgery 53 (2003) 34-38
43. Pathak A., Dutta S., Marwaha N., et al. Change in tissue thromboplastin content of brain following trauma. Neurol India 53 June (2) (2005) 178-182
44. Powner D.J., Hartwell E.A., and Hoots W.K. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 57 November (5) (2005) 823-831 [discussion 823-31]
45. Romagnoli S., Bevilacqua S., Gelsomino S., et al. Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery. Anesth Analg 102 May (5) (2006) 1320-1326
46. Sørensen B., Johansen P., Nielsen G.L., et al. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coag Fibrin 14 (2003) 469-477
47. Surudo T., Wojcicki M., and Milkiewicz P. Rapid correction of prothrombin time after low-dose recombinant factor VIIa in patients undergoing orthotopic liver transplantation. Transplant Proc 35 (2003) 2323-2325
48. ®). Anesthesiology 98 (2003) 1513-1515
49. Thomas G.O.R., Dutton R.P., Hemlock B., et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 62 3 (2007) 564-569
50. Waddington D.P., McAuley F.T., Hanley J.P., et al. The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. Br J Haematol 119 October (1) (2002) 286-288
51. Watson H., Salamat A., Tait, et al. Successful treatment of life threatening haemorrhage with rVIIa during autologous peripheral blood stem cell transplantation complicated by platelet refractoriness. Blood 100 (2002) 78b